Focus
Genetics Investors: Angels and VC Firms
The RaiseHunt database lists 1,411 Genetics investors: 28 angel investors and 1,383 people at 227 firms. Most list Series A and Seed among their stages; the largest hubs are San Francisco, Boston and New York.
Strongest in San Francisco, Boston and New York
- 1,411
- Genetics investors
- 28
- Angel investors
- 1,383
- People at VC/PE firms
- 227
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
1,411 Genetics investors
Showing 341-360
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
Gaurav Tuli Partner at F-Prime | Boston, United States | Venture capital | AIFinTech | ||
Steve Tregay Managing Partner at Mission BioCapital | Cambridge, United States | AcceleratorVenture capital | AIHealthcare | ||
Carter Neild Managing Partner at OrbiMed | New York, United States | Private equityVenture capital | AIHardware | ||
Ryan Carroll Managing Director at Charlesbank Capital Partners | Boston, United States | Private equityVenture debt | AIConsumer | ||
Mark Puttick CEO at Elysian Capital | London, United Kingdom | Private equity | |||
Matthew Nordan Managing Director at Prime Impact Fund | Boston, United States | Venture capital | ClimateFood | ||
Geoffrey Hsu General Partner at OrbiMed | New York, United States | Private equityVenture capital | AIHardware | ||
Peter Fong Partner, President at RTW Investments | New York, United States | Private equityVenture debt | Healthcare | ||
Matt Logan General Partner at Earthshot Ventures | San Francisco, United States | Venture capital | AIClimate | ||
Martin Taylor Principal at F-Prime | Boston, United States | Venture capital | AIFinTech | ||
Topher Orr Partner at OrbiMed | New York, United States | Private equityVenture capital | AIHardware | ||
Bill Snider Partner at BroadOak Capital Partners | Raleigh, United States | Private equityVenture debt | FinTechHardware | ||
Alexios Poyiadjis Investor at Blindspot Ventures | New York, United States | Venture capital | AIClimate | ||
Karthik Bolisetty Investor at Gilde Healthcare | United States | Private equityVenture capital | AIHardware | ||
Jesse Ge Principal at Charlesbank Capital Partners | Boston, United States | Private equityVenture debt | AIConsumer | ||
Phil Greves Partner at Elysian Capital | Leeds, United Kingdom | Private equity | |||
Bret Tenenhaus Principal at Great Point Partners | New York City, United States | Private equityVenture debt | FinTechHealthcare | ||
Fabio Pucci Co-Head of Healthcare Venture Investments at Leaps by Bayer | Boston, United States | Corporate VC | AIFood | ||
Michael Caspani Managing Director at BroadOak Capital Partners | Washington, United States | Private equityVenture debt | FinTechHardware | ||
Abdul Abdirahman Principal at F-Prime | New York, United States | Venture capital | AIFinTech |
Data: RaiseHunt investor dataset · Snapshot 2 October 2026 · How this data is built · Report a correction or request removal
